Benitec Biopharma (BNTC) Return on Capital Employed (2020 - 2025)
Historic Return on Capital Employed for Benitec Biopharma (BNTC) over the last 6 years, with Q1 2025 value amounting to 0.44%.
- Benitec Biopharma's Return on Capital Employed rose 10200.0% to 0.44% in Q1 2025 from the same period last year, while for Mar 2025 it was 0.44%, marking a year-over-year increase of 10200.0%. This contributed to the annual value of 0.96% for FY2024, which is 144200.0% up from last year.
- Latest data reveals that Benitec Biopharma reported Return on Capital Employed of 0.44% as of Q1 2025, which was up 10200.0% from 0.37% recorded in Q4 2024.
- In the past 5 years, Benitec Biopharma's Return on Capital Employed ranged from a high of 0.37% in Q4 2024 and a low of 8.07% during Q2 2023
- Its 5-year average for Return on Capital Employed is 1.75%, with a median of 1.29% in 2021.
- Per our database at Business Quant, Benitec Biopharma's Return on Capital Employed tumbled by -48200bps in 2023 and then surged by 72900bps in 2024.
- Over the past 5 years, Benitec Biopharma's Return on Capital Employed (Quarter) stood at 1.29% in 2021, then dropped by -14bps to 1.47% in 2022, then grew by 20bps to 1.18% in 2023, then soared by 68bps to 0.37% in 2024, then fell by -19bps to 0.44% in 2025.
- Its Return on Capital Employed stands at 0.44% for Q1 2025, versus 0.37% for Q4 2024 and 0.4% for Q3 2024.